1. aAnand, R.; Colandrea, V. J.; Reiter, M.; Vachal, P.; Zwicker, A.; Wilson, J. E.; Zhang, F.; Zhao, K. Benzopiperazine Derivatives as Cetp Inhibitors. WO 2013/028382 A1, 2013.
2. Discovery of Novel Indoline Cholesterol Ester Transfer Protein Inhibitors (CETP) through a Structure-Guided Approach
3. Discovery of Tetrahydroquinoxalines as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the Second Bromodomain
4. dKuhl, A.; Kolkhof, P.; Telan, L.; Peters, J.G.; Lustig, K.; Kast, R.; Münter, K.; Stasch, J.P.; Tinel, H. Tetrahydroquinoxalines and Their Use as M2 Acetylchloine Receptor Agonists. WO 2005/028451 A1, 2005.
5. eBissantz, C.; Dehmlow, H.; Erickson, S.; Kim, K.; Martin, R.; Sander, U.; Pietrancio-Cole, S.; Richter, H.; Ulmer, C. 4-Phenoxy-Nicotinamide or 4-Phenoxy-Pyridmidine-5-Carboxamide Compounds. US 2011/0178089, 2011.